Azyter eye drops
Azyter eye drops contain 1.5 % azithromycin for the treatment of purulent conjunctivitis, including conjunctivitis trachomatis caused by Chlamydia trachomatis.
A few more patients are free of symptoms after three days of using Azyter than when using eye drops containing tobramycin. Azyter is compared to tobramycin in a formulation that should be given more frequently than the prolonged release formulation that is marketed in Denmark. It is unknown how effective it is compared to other antibacterial eye drops used in Denmark.
Very common side effects are itching or a burning/stinging sensation in the eye after dripping. Common side effects are blurred vision and the sense of having a foreign object in the eye.
One treatment costs 97.65 Dkr, i.e. more than Tobrex Depot and twice the price of, the in Denmark frequently used preparation, Fucithalmic.
IRF finds that Azyter is an expensive alternative that has no documented advantages compared to the eye preparations most often used in Denmark.
There is no adequate data about the use of Azyter for treatment of children under 2 years old and people with contact lenses should not use Azyter.
Azyter is marketed February 20th 2012. It is available on prescription. It is not subject to reimbursement.
Institute for Rational Pharmacotherapy (IRF), February 20th 2012.